Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Stem Cell Innovations Advancing Drug Discovery With PluriCells

April 23, 2007

By Jennifer Boggs

Peregrine: Bavituximab Equivalent Effective In Mouse Glioma Model

April 19, 2007

By Jennifer Boggs

Peregrine: Bavituximab Equivalent Effective In Mouse Glioma Model

April 19, 2007

By Jennifer Boggs

HHS Ordering 20 Million Doses Of Bavarian Nordic's Imvamune

April 17, 2007

By Jennifer Boggs

HHS Ordering 20 Million Doses Of Bavarian Nordic's Imvamune

April 17, 2007

By Jennifer Boggs

Coley's VaxImmune Adjuvant Subject Of $37M Merck Deal

April 13, 2007

By Jennifer Boggs

Coley's VaxImmune Adjuvant Subject Of $37M Merck Deal

April 13, 2007

By Jennifer Boggs

Cell Genesys Boosting Cash Position Via $60M Stock Sale

April 12, 2007

By Jennifer Boggs

Cell Genesys Boosting Cash Position Via $60M Stock Sale

April 12, 2007

By Jennifer Boggs

Entereg Data Show Heart Risks, Adolor Plummets

April 11, 2007

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...